Cite
HARVARD Citation
Tamminga, M. et al. (2019). Circulating tumor cells in advanced non-small cell lung cancer patients are associated with worse tumor response to checkpoint inhibitors. Journal for immunotherapy of cancer. 7 (1), p. . [Online].